Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic...
Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic (MDT) on a Phase 2b clinical trial for Gencaro, ABIO's lead developmental drug for the treatment of cardiac rhythm disorders.
From other sites
at Benzinga.com (Jan 9, 2015)
at MarketWatch.com (Jun 9, 2011)
at MarketWatch.com (May 17, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs